MorphoSys AG (MOR)
17.58
+0.06
(+0.37%)
USD |
NASDAQ |
May 02, 13:13
MorphoSys Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| June 30, 2022 | -1.108B |
| March 31, 2022 | -893.98M |
| December 31, 2021 | -983.23M |
| September 30, 2021 | -1.229B |
| June 30, 2021 | 161.29M |
| March 31, 2021 | -964.56M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 88.98M |
| September 30, 2019 | -4.122M |
| June 30, 2019 | 44.19M |
| March 31, 2019 | -187.17M |
| December 31, 2018 | -209.89M |
| September 30, 2018 | -159.47M |
| June 30, 2018 | -167.90M |
| March 31, 2018 | -9.488M |
| December 31, 2017 | 37.30M |
| September 30, 2017 | -5.483M |
| June 30, 2017 | -70.73M |
| March 31, 2017 | -91.67M |
| December 31, 2016 | -89.41M |
| September 30, 2016 | 57.97M |
| June 30, 2016 | 59.65M |
| Date | Value |
|---|---|
| March 31, 2016 | 154.43M |
| December 31, 2015 | 95.73M |
| September 30, 2015 | -38.86M |
| June 30, 2015 | 8.732M |
| March 31, 2015 | -17.67M |
| December 31, 2014 | -28.59M |
| September 30, 2014 | -16.82M |
| June 30, 2014 | -270.69M |
| March 31, 2014 | -254.15M |
| December 31, 2013 | -257.46M |
| September 30, 2013 | -230.73M |
| June 30, 2013 | 3.620M |
| March 31, 2013 | -6.102M |
| December 31, 2012 | -15.54M |
| September 30, 2012 | -13.94M |
| June 30, 2012 | -12.71M |
| March 31, 2012 | -42.57M |
| December 31, 2011 | -25.23M |
| September 30, 2011 | -13.31M |
| June 30, 2011 | 5.671M |
| March 31, 2011 | 1.988M |
| December 31, 2010 | -2.646M |
| September 30, 2010 | -14.14M |
| June 30, 2010 | -28.68M |
| March 31, 2010 | -20.80M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.229B
Minimum
Sep 2021
161.29M
Maximum
Jun 2021
-543.18M
Average
-893.98M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
| Incyte Corp | -252.23M |
| Novartis AG | -5.924B |
| Immatics NV | -33.98M |
| Affimed NV | -39.04M |
| InflaRx NV | -19.16M |